SCHEMBL4970041

SCHEMBL4970041

CNC(C1CCCC1)C(C)NC(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 3/20 0.39
CA12 O43570 2/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA9 Q16790 2/20 0.39
EPHX1 P07099 5/20 0.38
ALDH1A1 P00352 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
LMNA P02545 1/20 0.33
CYP3A4 P08684 1/20 0.33
HPGD P15428 1/20 0.33
CYP2C19 P33261 1/20 0.33
RAB9A P51151 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MMP1 P03956 2/20 0.32
MMP9 P14780 2/20 0.32
MMP14 P50281 2/20 0.32
EPHX2 P34913 2/20 0.31
MMP3 P08254 1/20 0.31
HTR1E P28566 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4971712 0.98 MMP2 (0.41) MMP2CA12CA1CA2CA9
SCHEMBL4971492 0.98 MMP2 (0.41) MMP2CA12CA1CA2CA9
SCHEMBL4973637 0.86 MEN1 (0.31) EPHX1LMNAEPHX2
SCHEMBL4975006 0.82 PKM (0.31) SMN1; SMN2HPGD
SCHEMBL4971779 0.80 EPHX1 (0.41) MMP2CA12CA1CA2CA9
SCHEMBL4969967 0.77 GAA (0.41) CA1CA2EPHX1
SCHEMBL4975541 0.77 CA12 (0.44) MMP2CA12CA1CA2CA9
SCHEMBL4971473 0.76 GAA (0.43) MMP2CA12CA1CA2CA9
SCHEMBL4972585 0.76 GAA (0.43) MMP2CA12CA1CA2CA9
SCHEMBL26332503 0.76 ALDH1A1 (0.42) MMP2CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966139-A1 ASPARTIC PROTEASE INHIBITORS Vitae Pharmaceuticals, Inc. (US) 2008-09-10 EP disclosed
WO-2007070201-A1 ASPARTIC PROTEASE INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2007-06-21 WO disclosed